This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Nippon Suisan Kaisha, Ltd.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Akihisa Abe: Innovator in Antitumor Compounds
Introduction
Akihisa Abe is a notable inventor based in Hachioji, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antitumor activity. His work has implications for cancer treatment and showcases the importance of innovation in medical research.
Latest Patents
Abe holds a patent for a tricyclic condensed heterocyclic compound, which is derived from the culture product of an actinomycete. This compound exhibits antitumor activity and can be represented by specific chemical formulas. The patent details a process for producing this compound and its potential uses in pharmaceuticals. He has 1 patent to his name, highlighting his contributions to the field.
Career Highlights
Abe is associated with Nippon Suisan Kaisha, Ltd., where he has been involved in research and development efforts. His work at the company emphasizes the intersection of biotechnology and pharmaceuticals, aiming to create effective treatments for serious health conditions.
Collaborations
Throughout his career, Abe has collaborated with notable colleagues, including Seizo Sato and Fumie Iwata. These partnerships have likely enhanced the research and development process, leading to innovative solutions in the pharmaceutical industry.
Conclusion
Akihisa Abe's contributions to the field of antitumor compounds reflect his dedication to advancing medical science. His innovative work continues to inspire future research and development in pharmaceuticals.